Directed new share issue in Clavis Pharma ASA (NO) — NOK 129 million

Carnegie acted as joint lead manager and joint book-runner in the directed new share issue of 10.8 million shares, at a price of NOK 12.00 per share. Clavis Pharma ASA is an oncology focused pharmaceutical company.June, 2009.